Accurate assessment of beta-cell function: the hyperbolic correction.
about
The metabolic consequences of sleep deprivationThe Elevated Susceptibility to Diabetes in India: An Evolutionary PerspectiveNovel phenotypes of prediabetes?Dysglycemia after renal transplantation: Definition, pathogenesis, outcomes and implications for managementInterventions to preserve beta-cell function in the management and prevention of type 2 diabetesThe artificial pancreas: is it important to understand how the β cell controls blood glucose?Exercise as an intervention to improve metabolic outcomes after intrauterine growth restrictionβ-cell dysfunction: Its critical role in prevention and management of type 2 diabetes.Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome.Obesity: from the agricultural revolution to the contemporary pediatric epidemic.Genetics of glucose homeostasis: implications for insulin resistance and metabolic syndrome.Fructose: it's "alcohol without the buzz".Candidate loci for insulin sensitivity and disposition index from a genome-wide association analysis of Hispanic participants in the Insulin Resistance Atherosclerosis (IRAS) Family Study.Evaluation of DLG2 as a positional candidate for disposition index in African-Americans from the IRAS Family Study.Alterations in ventricular structure and function in obese adolescents with nonalcoholic fatty liver disease.Slow-wave sleep and the risk of type 2 diabetes in humans.Lack of association between the tagging SNP A+930-->G of SOCS3 and type 2 diabetes mellitus: meta-analysis of four independent study populations.Weight loss therapy improves pancreatic endocrine function in obese older adultsThe metabolic syndromeAssociations of free fatty acids with insulin secretion and action among African-American and European-American girls and womenHNF1α defect influences post-prandial lipid regulation.Improvements in glucose homeostasis in response to regular exercise are influenced by the PPARG Pro12Ala variant: results from the HERITAGE Family StudyCarriers of loss-of-function mutations in ABCA1 display pancreatic beta-cell dysfunctionPost-meal β-cell function predicts the efficacy of glycemic control in patients with type 2 diabetes inadequately controlled by metformin monotherapy after addition of glibenclamide or acarbosePathophysiology of type 2 diabetes mellitus in youth: the evolving chameleon.β-Cell Replacement Strategies: The Increasing Need for a "β-Cell Dogma".Acute administration of unacylated ghrelin has no effect on Basal or stimulated insulin secretion in healthy humans.Diabetes Prevention for Latino Youth: Unraveling the Intervention "Black Box"Variation in the FFAR1 gene modifies BMI, body composition and beta-cell function in overweight subjects: an exploratory analysisDeclining beta-cell function relative to insulin sensitivity with increasing fasting glucose levels in the nondiabetic range in childrenMatched weight loss induced by sleeve gastrectomy or gastric bypass similarly improves metabolic function in obese subjects.Impact of serum triglyceride and high density lipoprotein cholesterol levels on early-phase insulin secretion in normoglycemic and prediabetic subjects.Improvement in ß-cell function in patients with normal and hyperglycemia following Roux-en-Y gastric bypass surgery.Hepatic portal vein denervation impairs oral glucose tolerance but not exenatide's effect on glycemia.Altered glucose homeostasis is associated with increased serum apelin levels in type 2 diabetes mellitus.Sodium phenylbutyrate, a drug with known capacity to reduce endoplasmic reticulum stress, partially alleviates lipid-induced insulin resistance and beta-cell dysfunction in humansModified minimal model for effect of physical exercise on insulin sensitivity and glucose effectiveness in type 2 diabetes and healthy human.Adiposity and β-cell function: relationships differ with ethnicity and ageAge-related changes in insulin sensitivity and β-cell function among European-American and African-American women.Insulin dynamics predict body mass index and z-score response to insulin suppression or sensitization pharmacotherapy in obese children
P2860
Q24681664-284D82E5-D6B3-4651-8FDF-FCFC31006EF6Q26741534-C0D63CDF-DE98-4314-90B7-6F0FD536D6F2Q26747128-9BF9A00F-1DF9-4FF0-84D0-5FD00A234684Q26795773-5EC5E734-50B0-4D10-A32B-989605D277A9Q26830871-076ECA85-2E5D-424A-AEF5-039110F78106Q26852992-1DB69E83-0645-4BB8-87A6-31CD5F4B8AF1Q27021167-BF34D207-ADDA-4109-ACE2-B1B88F75D45BQ27692665-046B9EAA-9E17-45C6-8616-4517D14C8951Q28390200-B81E5344-61D1-4A66-A073-EC459725ED3AQ30412544-CAC295C5-0604-4600-86E0-B4DA2F573847Q30413807-7D4AFFC5-EC17-4181-A433-B0FBF409F05FQ30428239-243D9069-F6D7-4B2D-B123-462A0318C0F8Q30433331-BE6277C7-CB16-47D6-9ED8-F8DC00A971BFQ30433623-2B1CECC7-C5ED-40B3-9EBB-5737670243FAQ30437623-18F88C54-097F-4AC5-8EE4-F4D872C0B8DEQ30481284-CD517542-0491-4B28-987A-D7344BC0FD6EQ33389180-CA972F92-B32B-4690-B666-3FAC17B6050AQ33565059-AEE394F3-DCDB-4A31-9EA3-3670A6C7CCC8Q33569142-0390F2D0-268D-4D67-A619-91780DBDDB16Q33621212-4042C4FC-0421-47BE-8D31-2440C399E7B8Q33663991-9A491F11-6215-4405-87F8-D974F5824B22Q33735643-0A859FAD-FFF3-4EFE-BA6C-8391115FA907Q33751570-3EA11A0B-0AFD-4069-81A9-A30AF0C71CCBQ33756059-5A8F0A31-B1AF-4DBC-A495-019F34AAFBDDQ33757408-E413C3FF-9B52-41EC-99E2-7BC6B81CE1F5Q33766081-4119E573-B943-4BA7-B05E-4273A03579B9Q33789384-6844107C-4F2A-46E1-B2C1-B0573196A3FEQ33878588-D05B3197-37A5-4C00-8011-DC94BE4A76ACQ33892691-0806E8B9-C141-45BA-A6F3-D7B3F1F4339BQ34084580-A7A11D22-0F90-45CC-A9BE-89AB04B5D862Q34110731-1A1FCA74-0B46-4E70-BAC9-4BC3FE123EA2Q34161905-07B2AD6C-4FC8-458A-A011-D72D5E92C9ACQ34305172-56AD61F2-7B65-4DD1-BC76-CD5F75E41CD2Q34355968-A28C6AED-8588-4648-BFBE-F545CA0D378EQ34507329-AACFF54C-E35B-442B-912F-7D9EBCF2A65EQ34615491-EFCD5689-9368-4DF6-8039-EE974B13169AQ34663222-EAFDA65C-C9F4-4D2A-8BBA-FEEB53A7B3A4Q34781467-B18BA4F0-31CC-428C-99E7-D6F4EFC0A011Q34781491-5B6F9046-69F7-4AD0-8FDD-9987507E1531Q34997528-CFF58236-3714-4D15-9692-9F21F92E8985
P2860
Accurate assessment of beta-cell function: the hyperbolic correction.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Accurate assessment of beta-cell function: the hyperbolic correction.
@ast
Accurate assessment of beta-cell function: the hyperbolic correction.
@en
Accurate assessment of beta-cell function: the hyperbolic correction.
@nl
type
label
Accurate assessment of beta-cell function: the hyperbolic correction.
@ast
Accurate assessment of beta-cell function: the hyperbolic correction.
@en
Accurate assessment of beta-cell function: the hyperbolic correction.
@nl
prefLabel
Accurate assessment of beta-cell function: the hyperbolic correction.
@ast
Accurate assessment of beta-cell function: the hyperbolic correction.
@en
Accurate assessment of beta-cell function: the hyperbolic correction.
@nl
P2093
P1433
P1476
Accurate assessment of beta-cell function: the hyperbolic correction.
@en
P2093
Gregg Van Citters
Katrin Huecking
Marilyn Ader
Richard N Bergman
P304
P356
10.2337/DIABETES.51.2007.S212
P407
P478
51 Suppl 1
P577
2002-02-01T00:00:00Z